Increased plasma big ET-1 was associated with a higher risk of adverse cardiovascular prognosis independent of traditional and angiographic risk factors, and therefore it might be used as a prognostic/predictive biomarker in patients with ISR and diabetes. Here, EDN1 is linked to diabetes mellitus.